TCT-725 Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With Coronary Artery DiseaseDavid Erlinge, Paul A. Gurbel, Suman Duvvuru et al.|Journal of the American College of Cardiology|2012Cited by 1